Evidence map›Paper›PMID 18640985›Full record

ArticleThe Journal of biological chemistry2008

Separate cis-trans pathways post-transcriptionally regulate murine CD154 (CD40 ligand) expression: a novel function for CA repeats in the 3'-untranslated region.

B JoNell Hamilton, Xiao-Wei Wang, Jane Collins, Donald Bloch, Alan Bergeron, Brian Henry, Benjamin M Terry, Moe Zan, Andrew J Mouland, William F C Rigby

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

B JoNell HamiltonDepartment of Medicine, Lebanon, New Hampshire 03756.
Xiao-Wei WangDepartment of Medicine, Lebanon, New Hampshire 03756.
Jane CollinsDepartment of Medicine, Lebanon, New Hampshire 03756.
Donald BlochDivision of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114.
Alan BergeronDepartment of Microbiology and Immunology, Dartmouth Medical School, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire 03756.
Brian HenryDepartment of Medicine, Lebanon, New Hampshire 03756.
Benjamin M TerryNew York Medical College, Valhalla, New York 10595.
Moe ZanDepartment of Medicine, Lebanon, New Hampshire 03756.
Andrew J MoulandLady Davis Institute for Medical Research and McGill University, Montreal, Quebec H3T 1E2, Canada.
William F C RigbyDepartment of Medicine, Lebanon, New Hampshire 03756; Department of Microbiology and Immunology, Dartmouth Medical School, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire 03756. Electronic address: William.Rigby@Dartmouth.edu.
Dartmouth Psychiatric Research Center · USDartmouth–Hitchcock Medical Center · USMassachusetts General Hospital · USMcGill University · CANew York Medical College · US

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Steven D Leach · 1985 to 2026
$91.3M
IMMUNOBIOLOGY OF MYELOID AND LYMPHOID CELLST32AI007363 · NIAID · DARTMOUTH COLLEGE · PI Claudia V Jakubzick · 1990 to 2026
$9.5M
REGULATION OF CD154 EXPRESSIONR01AR049834 · NIAMS · DARTMOUTH COLLEGE · PI RIGBY, WILLIAM FREDERICK CARSON · 2003 to 2010
$2.4M
NCI NIH HHS P30 CA023108NIAID NIH HHS T32 AI007363NIAID NIH HHS T32 AI 07363NIAMS NIH HHS R01 AR049834NIAMS NIH HHS R01 AR 49834
6 · The paper itself

Abstract

We report a role for CA repeats in the 3'-untranslated region (3'-UTR) in regulating CD154 expression. Human CD154 is encoded by an unstable mRNA; this instability is conferred in cis by a portion of its 3'-UTR that includes a polypyrimidine-rich region and CA dinucleotide repeat. We demonstrate similar instability activity with the murine CD154 3'-UTR. This instability element mapped solely to a conserved 100-base CU-rich region alone, which we call a CU-rich response element. Surprisingly, the CA dinucleotide-rich region also regulated reporter expression but at the level of translation. This activity was associated with poly(A) tail shortening and regulated by heterogeneous nuclear ribonucleoprotein L levels. We conclude that the CD154 3'-UTR contains dual cis-acting elements, one of which defines a novel function for exonic CA dinucleotide repeats. These findings suggest a mechanism for the association of 3'-UTR CA-rich response element polymorphisms with CD154 overexpression and the subsequent risk of autoimmune disease.

Indexed as

Gene Expression RegulationRNA Processing, Post-Transcriptional3' Untranslated RegionsAnimalsAutoimmune DiseasesBase SequenceCattleCD40 LigandHeterogeneous-Nuclear Ribonucleoprotein LHumansMiceMolecular Sequence DataPoly APolymorphism, GeneticRepetitive Sequences, Nucleic Acid3' Untranslated RegionsCD40 LigandHeterogeneous-Nuclear Ribonucleoprotein LPoly A

Identifiers

PMID18640985
PMCPMC2533087
OpenAlexW1997882620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.